Insight & Updates

Insights & Updates

Insights, Research & Industry Updates

New Joint Venture to manufacture GMP theranostic radiopharmaceuticals in Australia

Cyclotek’s journey from lab to first-in-human: bettering cancer diagnostics to improve patient outcomes

A Conversation with Pamela Naidoo-Ameglio from ANSTO on Women In Nuclear

GenesisCare in collaboration with Cyclotek, conducts a 100 patient prospective trial on the use of 18F-DCFPyL (PSR) PET/CT in men with detectable PSA post-prostatectomy.

Cyclotek and AANMS lodge application to MSAC seeking MBS rebate for Australian Prostate Cancer patients.

Cyclotek announces partnership with Women in Nuclear Australia

Cyclotek collaborated with FREO2 Foundation in donating medical oxygen equipment towards the COVID-19 treatment efforts in Uganda

Cyclotek Staff Initiative Generates $10,000 in Donations for Emergency Bushfire Appeal – January 2020

Cyclotek Initiates the Direct-Action Donation (DAD) of $45,000 for the Think Pink Foundation.